Contract facts
FederalPROGRAM MANAGEMENT is a federal award for Amsam-Spk held by Raytheon Company. Estimated value $5.7M ($5.6M obligated). Current period of performance ends Apr 30, 2026. Place of performance: MCKINNEY TX. Related solicitation H9224120R0017.
Recompete timing
PublicCurrent PoP ended Apr 30, 2026 (113 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRaytheon Company — $2.6B obligated across 311 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract H9224125F0046?
H9224125F0046 (Program management) is a Amsam-Spk award with a potential value of $5.7M, currently held by Raytheon Company. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is H92241-25-F-0046?
H92241-25-F-0046 is the dashed form of PIID H9224125F0046 (Program management), held by Raytheon Company. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded H9224125F0046?
Amsam-Spk awarded H9224125F0046 to Raytheon Company (potential $5.7M).
Who is the incumbent on H9224125F0046?
Raytheon Company is the incumbent with $2.6B across 311 related awards in SCOUT’s public footprint. The current period of performance ends Apr 30, 2026.
When does Raytheon Company’s H9224125F0046 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.